Lawmakers have focused on the high cost of diabetes drugs. The announcement will make state-branded insulin available two ...
The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...
The acceptance comes after a study done by the American Diabetes Association in June found that inhaled insulin is safe and ...
The sale of insulin is part of the state’s CalRx initiative aimed at lowering prescription drug prices for Californians.
Gov. Gavin Newsom announced Thursday that the state would provide insulin shots for $11, far below market prices.
The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.
Long-acting insulin pens will be available at pharmacies for $11 per pen — or $55 for a five-pack — beginning Jan. 1.
California will soon become the first state to offer its own affordable insulin, with Gov. Gavin Newsom announcing that CalRx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback